Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:2716-2721
doi: 10.1161/hc4601.099404
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, L.
Right arrow Articles by Horiuchi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, L.
Right arrow Articles by Horiuchi, M.
Related Collections
Right arrow ACE/Angiotension receptors

(Circulation. 2001;104:2716.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Roles of Angiotensin II Type 2 Receptor Stimulation Associated With Selective Angiotensin II Type 1 Receptor Blockade With Valsartan in the Improvement of Inflammation-Induced Vascular Injury

Lan Wu, MD; Masaru Iwai, MD, PhD; Hironori Nakagami, MD; Zhen Li, MD; Rui Chen, MD; Jun Suzuki, MD; Masahiro Akishita, MD, PhD; Marc de Gasparo, MD, PhD; Masatsugu Horiuchi, MD, PhD

From the Department of Medical Biochemistry, Ehime University School of Medicine, Ehime (L.W., M.I., H.N., Z.L., R.C., J.S., M.H.), and the Department of Geriatric Medicine, Kyorin University School of Medicine, Tokyo (M.A.), Japan; and Novartis Pharma AG, Basel, Switzerland (M.d.G.).

Correspondence to Masatsugu Horiuchi, MD, PhD, Department of Medical Biochemistry, Ehime University School of Medicine, Shigenobu, Onsen-gun, Ehime 791-0295, Japan. E-mail horiuchi{at}m.ehime-u.ac.jp

Background— To investigate the effect of angiotensin (Ang) II type 1 receptor (AT1) blocker on vascular remodeling and explore the possibility of the involvement of Ang II type 2 receptor (AT2) stimulation in this process, we examined the effects of the selective AT1 blocker valsartan on the vascular injury in wild-type (Agtr2+) and AT2-null (Agtr2-) mice.

Methods and Results— Neointima formation and the proliferation of vascular smooth muscle cells (VSMCs) induced by cuff placement on the femoral artery were greater in Agtr2- mice than those in Agtr2+ mice. Treatment of mice with valsartan at a dose of 1 mg · kg-1 · d-1, which did not influence systolic blood pressure, significantly decreased neointima formation and the proliferation of VSMCs, whereas the valsartan was less effective in Agtr2- mice. Moreover, cuff placement increased the expression of monocyte chemoattractant protein-1 (MCP-1); inflammatory cytokines such as tumor necrosis factor (TNF)-{alpha}, interleukin (IL)-6, and IL-1ß; and infiltration of CD45-positive leukocytes and macrophages in the injured arteries and further enhanced them in Agtr2- mice, suggesting the antagonistic effects of AT1 and AT2 for vascular inflammation. Valsartan attenuated the expression of MCP-1, TNF-{alpha}, IL-6, IL-1ß, and infiltration of leukocytes and macrophages in the injured arteries; however, these effects of valsartan were less prominent in Agtr2- mice.

Conclusions— These results suggest that the stimulation of the AT2 receptor after AT1 blockade is important in the improvement of the inflammatory vascular injury.


Key Words: angiotensin • arteries • inflammation • receptors • remodeling